Target intelligence / Profile preview

Microbial electron transport cytochromes

Molecular classification
Enzyme, Oxidoreductase, Heme-protein
01

Overview

Microbial electron transport cytochromes are heme-containing proteins that play a central role in the respiratory chains of bacteria, archaea, and some fungi. These proteins facilitate the sequential transfer of electrons from donors like NADH or succinate to terminal acceptors such as oxygen, a process coupled to the generation of a proton gradient for ATP synthesis (Borisov et al., 2021). In pathogenic organisms like Mycobacterium tuberculosis, specific complexes such as the cytochrome bcc complex and the cytochrome bd oxidase are vital for metabolic flexibility and survival within the host environment (Pethe et al., 2013). Because certain microbial cytochromes, particularly the bd-type oxidases, are structurally distinct from human mitochondrial cytochromes, they serve as attractive targets for selective antimicrobial therapy (Cook et al., 2021). Inhibitors like Telacebec (Q203) target the QcrB subunit of the bcc complex, leading to a rapid depletion of intracellular ATP and bacterial death (Kang et al., 2014). Research into these targets is particularly focused on overcoming multi-drug resistance in tuberculosis and other recalcitrant bacterial infections.

Other names
Bacterial respiratory cytochromesCytochrome bcc complexCytochrome bd oxidaseCytochrome c oxidase (microbial)Heme-proteins of the microbial respiratory chain
02

Mechanism of action

Inhibition of electron transfer through the cytochrome complexes, typically by binding to the quinol oxidation (Qo) or reduction (Qi) sites, thereby disrupting the proton motive force and ATP production.

03

Biological functions

Cellular respirationElectron transportEnergy metabolismRedox homeostasis
04

Disease associations

Infection
05

Safety considerations

Potential for mitochondrial toxicity if selectivity for microbial vs. human cytochromes is insufficientDevelopment of compensatory respiratory pathways (e.g., cytochrome bd upregulation when bcc is inhibited)
06

Interacting drugs

Telacebec (Q203)

4 more in the full profile.

07

Biomarkers

Intracellular ATP levelsOxygen consumption rate (OCR)Bacterial growth inhibition

Beyond the preview

Go deeper on Microbial electron transport cytochromes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial electron transport cytochromes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call